消化器内科
消化器内科業績
- "Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype. " Kagami T, Yamade M, Suzuki T, Uotani T, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Umemura K, Miyajima H, Furuta T: Clin Pharmacol Ther 103: 906-913, 2018.
- "High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication. " Furuta T, Baba S, Yamade M, Uotani T, Kagami T, Suzuki T, Tani S, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K. Aliment Pharmacol Ther 48: 370-377, 2018.
- "A Rare Cause of a Rectal Tumor-like Lesion." Sugimoto K, Shimura E, Osawa S: Gastroenterology 154: 2039-2040, 2018.
英文業績
1. Sugimoto K, Ikeya K, Kato M, Matsuura A, Watanabe F, Takano R, Tamura S, Tani S, Osawa S, Hanai H. Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice. Dig Dis 37: 11-20, 2019.
2. Takano R, Osawa S, Uotani T, Tani S, Ishida N, Tamura S, Yamade M, Iwaizumi M, Hamaya Y, Furuta T, Miyajima H, Sugimoto K. Evaluating mucosal healing using colon capsule endoscopy predicts outcome in patients with ulcerative colitis in clinical remission. World J Clin Cases 6: 952-960, 2018.
3. Mori T, Hamaya Y, Uotani T, Yamade M, Iwaizumi M, Furuta T, Miyajima H, Osawa S, Sugimoto K. Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma. PLoS One 13: e0208557, 2018.
4. Suzuki T, Kagami T, Uotani T, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Miyajima H, Furuta T: Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin. Eur J Clin Pharmacol 74: 45-52, 2018.
5. Rajapakse VN, Luna A, Yamade M(First-co author), Loman L, Varma S, Sunshine M, Iorio F, Sousa FG, Elloumi F, Aladjem MI, Thomas A, Sander C, Kohn KW, Benes CH, Garnett M, Reinhold WC, Pommier Y.: CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines. iScience, 10: 247-264, 2018.
6. Kagami T, Yamade M, Suzuki T, Uotani T, Tani S, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Baba S, Sugimura H, Miyajima H, Furuta T. High expression level of CD44v8-10 in cancer stem-like cells is associated with poor prognosis in esophageal squamous cell carcinoma patients treated with chemoradiotherapy Oncotarget 79 (9): 3487688, 2018.
7. Kagami T, Yamade M, Suzuki T, Uotani T, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Umemura K, Miyajima H, Furuta T: Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype. Clin Pharmacol Ther 103: 906-913, 2018.
8. Uotani T, Murakami K, Uchida T, Tanaka S, Nagashima H, Zeng XL, Akada J, Estes MK, Graham DY, Yamaoka Y. Changes of tight junction and interleukin-8 expression using a human gastroid monolayer model of Helicobacter pylori infection. Helicobacter. 24(3): e12583, 2019.
9. Furuta T, Baba S, Yamade M, Uotani T, Kagami T, Suzuki T, Tani S, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K. High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication. Aliment Pharmacol Ther 48: 370-377, 2018.
10. Sakao Y, Ohashi N, Sugimoto M, Ichikawa H, Sahara S, Tsuji T, Kato A, Fujigaki Y, Sugimoto K, Furuta T, Yasuda H. Gender differences in plasma ghrelin levels in hemodialysis patients. Ther Apher Dial 23:65-72, 2018.
11. Yamamoto T, Iida T, Ikeya K, Kato M, Matsuura A, Tamura S, Takano R, Tani S, Osawa S, Sugimoto K, Shimoyama T, Hanai H. A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis. Clin Transl Gastroenterol 9: 170, 2018.
12. Kikuyama M, Shirane N, Kawaguchi S, Terada S, Mukai T, Sugimoto K: New 14-mm diameter Niti-S biliary uncovered metal stent for unresectable distal biliary malignant obstruction. World J Gastrointest Endosc 10: 16-22, 2018.
13. Sahara S, Sugimoto M, Ichikawa H, Kagami T, Sakao Y, Ohashi N, Horio Y, Sugimoto K, Kato A, Furuta T, Yasuda H: Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial. Digestion 97: 163-169, 2018.
14. Ichikawa H, Sugimoto M, Sakao Y, Sahara S, Ohashi N, Sano K, Tadokoro S, Azekura H, Shimomura A, Yamashita F, Sugiyama D, Fukuta K, Furuta T, Kato A, Sugimoto K, Yasuda H. Eradication therapy for Helicobacter pylori infection improves nutrition status in Japanese hemodialysis patients: a pilot study. J Clin Biochem Nutr. 64(1):91-95, 2019.
15. Sakao Y,Ohashi N,Sugimoto M,Ichikawa H,Sahara S,Tsuji T,Kato A,Fujigaki Y,Sugimoto K,Furuta T,Yasuda H.Gender Differences in Plasma Ghrelin Levels in Hemodialysis Patients.Ther Apher Dial. 23(1):65-72, 2019.
16. Sugimoto K, Shimura E, Osawa S: A Rare Cause of a Rectal Tumor-like Lesion. Gastroenterology 154: 2039-2040, 2018.
邦文総説など
1. 鏡 卓馬, 古田 隆久, 山出 美穂子, 魚谷 貴洋, 鈴木 崇弘 感染症における宿主の遺伝的多様性と病態(解説/特集) 遺伝子医学MOOK (1349-2527)別冊最新多因子遺伝性疾患研究と遺伝カウンセリング Page200-203, 2018
2. 鏡 卓馬，古田隆久，【モニタリングから介入まで 自信をもって対応できる薬物相互作用】 抗血小板薬とPPIとの薬物相互作用(解説/特集)、薬事 (0016-5980)61巻4号 Page613-618(2019.03)
1. Sugimoto K, Ikeya K, Kato M, Matsuura A, Watanabe F, Takano R, Tamura S, Tani S, Osawa S, Hanai H. Assessment of Long-Term Efficacy and Safety of Adalimumab in Patients with Ulcerative Colitis: Results from a 6-Year Real-World Clinical Practice. Dig Dis 37: 11-20, 2019.
2. Takano R, Osawa S, Uotani T, Tani S, Ishida N, Tamura S, Yamade M, Iwaizumi M, Hamaya Y, Furuta T, Miyajima H, Sugimoto K. Evaluating mucosal healing using colon capsule endoscopy predicts outcome in patients with ulcerative colitis in clinical remission. World J Clin Cases 6: 952-960, 2018.
3. Mori T, Hamaya Y, Uotani T, Yamade M, Iwaizumi M, Furuta T, Miyajima H, Osawa S, Sugimoto K. Prevalence of elevated microsatellite alterations at selected tetranucleotide repeats in pancreatic ductal adenocarcinoma. PLoS One 13: e0208557, 2018.
4. Suzuki T, Kagami T, Uotani T, Yamade M, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Miyajima H, Furuta T: Comparison of effect of an increased dosage of vonoprazan versus vonoprazan plus lafutidine on gastric acid inhibition and serum gastrin. Eur J Clin Pharmacol 74: 45-52, 2018.
5. Rajapakse VN, Luna A, Yamade M(First-co author), Loman L, Varma S, Sunshine M, Iorio F, Sousa FG, Elloumi F, Aladjem MI, Thomas A, Sander C, Kohn KW, Benes CH, Garnett M, Reinhold WC, Pommier Y.: CellMinerCDB for Integrative Cross-Database Genomics and Pharmacogenomics Analyses of Cancer Cell Lines. iScience, 10: 247-264, 2018.
6. Kagami T, Yamade M, Suzuki T, Uotani T, Tani S, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Baba S, Sugimura H, Miyajima H, Furuta T. High expression level of CD44v8-10 in cancer stem-like cells is associated with poor prognosis in esophageal squamous cell carcinoma patients treated with chemoradiotherapy Oncotarget 79 (9): 3487688, 2018.
7. Kagami T, Yamade M, Suzuki T, Uotani T, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K, Umemura K, Miyajima H, Furuta T: Comparative Study of Effects of Vonoprazan and Esomeprazole on Antiplatelet Function of Clopidogrel or Prasugrel in Relation to CYP2C19 Genotype. Clin Pharmacol Ther 103: 906-913, 2018.
8. Uotani T, Murakami K, Uchida T, Tanaka S, Nagashima H, Zeng XL, Akada J, Estes MK, Graham DY, Yamaoka Y. Changes of tight junction and interleukin-8 expression using a human gastroid monolayer model of Helicobacter pylori infection. Helicobacter. 24(3): e12583, 2019.
9. Furuta T, Baba S, Yamade M, Uotani T, Kagami T, Suzuki T, Tani S, Hamaya Y, Iwaizumi M, Osawa S, Sugimoto K. High incidence of autoimmune gastritis in patients misdiagnosed with two or more failures of H. pylori eradication. Aliment Pharmacol Ther 48: 370-377, 2018.
10. Sakao Y, Ohashi N, Sugimoto M, Ichikawa H, Sahara S, Tsuji T, Kato A, Fujigaki Y, Sugimoto K, Furuta T, Yasuda H. Gender differences in plasma ghrelin levels in hemodialysis patients. Ther Apher Dial 23:65-72, 2018.
11. Yamamoto T, Iida T, Ikeya K, Kato M, Matsuura A, Tamura S, Takano R, Tani S, Osawa S, Sugimoto K, Shimoyama T, Hanai H. A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis. Clin Transl Gastroenterol 9: 170, 2018.
12. Kikuyama M, Shirane N, Kawaguchi S, Terada S, Mukai T, Sugimoto K: New 14-mm diameter Niti-S biliary uncovered metal stent for unresectable distal biliary malignant obstruction. World J Gastrointest Endosc 10: 16-22, 2018.
13. Sahara S, Sugimoto M, Ichikawa H, Kagami T, Sakao Y, Ohashi N, Horio Y, Sugimoto K, Kato A, Furuta T, Yasuda H: Efficacy of Reduced Dosage of Amoxicillin in an Eradication Therapy for Helicobacter pylori Infection in Patients on Hemodialysis: A Randomized Controlled Trial. Digestion 97: 163-169, 2018.
14. Ichikawa H, Sugimoto M, Sakao Y, Sahara S, Ohashi N, Sano K, Tadokoro S, Azekura H, Shimomura A, Yamashita F, Sugiyama D, Fukuta K, Furuta T, Kato A, Sugimoto K, Yasuda H. Eradication therapy for Helicobacter pylori infection improves nutrition status in Japanese hemodialysis patients: a pilot study. J Clin Biochem Nutr. 64(1):91-95, 2019.
15. Sakao Y,Ohashi N,Sugimoto M,Ichikawa H,Sahara S,Tsuji T,Kato A,Fujigaki Y,Sugimoto K,Furuta T,Yasuda H.Gender Differences in Plasma Ghrelin Levels in Hemodialysis Patients.Ther Apher Dial. 23(1):65-72, 2019.
16. Sugimoto K, Shimura E, Osawa S: A Rare Cause of a Rectal Tumor-like Lesion. Gastroenterology 154: 2039-2040, 2018.
邦文総説など
1. 鏡 卓馬, 古田 隆久, 山出 美穂子, 魚谷 貴洋, 鈴木 崇弘 感染症における宿主の遺伝的多様性と病態(解説/特集) 遺伝子医学MOOK (1349-2527)別冊最新多因子遺伝性疾患研究と遺伝カウンセリング Page200-203, 2018
2. 鏡 卓馬，古田隆久，【モニタリングから介入まで 自信をもって対応できる薬物相互作用】 抗血小板薬とPPIとの薬物相互作用(解説/特集)、薬事 (0016-5980)61巻4号 Page613-618(2019.03)